Jim joined the Mundipharma network in 2010, initially as Head of Medical Affairs for oncology and then taking on responsibilities for new products. He moved into the Corporate and Business Development team in 2012 and is now responsible for business development, acquisitions, technology sourcing and strategic collaborations, along with alliance management.
He began his pharmaceutical career in 2002 at Fujisawa and then Astellas Pharma, where he held various positions in R&D, medical and marketing in a wide variety of therapeutic areas. Previously, Jim worked in academia for various leading institutions including the Institute of Child Health at The Hospital for Sick Children, Great Ormond Street, in haematology and oncology, and the Institute of Cancer Research, Royal Marsden Hospital.
Jim holds a degree in Medicinal Chemistry from University College London.
Press return to search